Machine learning vs. conventional methods for prediction of 30-day readmission following percutaneous mitral

Samian Sulaiman1, Akram Kawsara1, Abdallah El Sabbagh2

  • 1Division of Cardiology, West Virginia University, Morgantown, WV, United States of America.

Abstract

Insights

Machine learning models show promise in predicting 30-day readmissions after mitral valve transcatheter edge-to-edge repair (MV-TEER). Algorithms like Naive Bayes and ML-logistic regression outperformed traditional methods, aiding in patient risk stratification.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Health Services Research

Background:

  • Predicting readmissions after mitral valve transcatheter edge-to-edge repair (MV-TEER) is crucial for patient care.
  • Identifying key predictors aids in risk stratification and optimizing outcomes.

Purpose of the Study:

  • To compare the predictive performance of machine learning (ML) algorithms against traditional logistic regression for MV-TEER readmissions.
  • To identify optimal ML models for predicting post-MV-TEER readmissions using administrative data.

Main Methods:

  • Utilized the National Readmission Database (2015-2018) for patients undergoing MV-TEER.
  • Applied Lasso regression for variable selection, testing 4 ML models (ML-LR, Naive Bayes, RF, ANN) and PCA-LR.
  • Split data into 70% training and 30% testing sets.

Main Results:

  • Included 9,425 index hospitalizations; 30-day readmission rate was 14.6%, with heart failure as the primary cause.
  • ML-logistic regression (AUC 0.692) and Naive Bayes (AUC 0.724) significantly outperformed traditional PCA-LR (AUC 0.615).
  • Readmitted patients had higher comorbidity and frailty scores, longer stays, and more non-home discharges.

Conclusions:

  • Machine learning algorithms demonstrate superior ability in predicting 30-day readmissions post-MV-TEER compared to traditional methods.
  • ML models offer a valuable tool for risk stratification using large administrative databases.
  • Further development of ML tools can enhance clinical decision-making for MV-TEER patients.

Related Concept Videos